Pre-study | Week 1 | Week 2 | Week 3 | Week 4 | Week 5 | Week 6 | Week 7 | Week 8 | Weeks 9–11 | Week 12 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Phone screen | X | ||||||||||
Randomization | X | ||||||||||
SCIP | X | ||||||||||
C-SSRS | X | X | X | ||||||||
Medical history | X | ||||||||||
ICF | X | ||||||||||
Sociodemographics | X | X | X | ||||||||
Medication review | X | X | X | X | |||||||
IOS Scale | X | X | X | X | |||||||
SIQ | X | X | X | X | |||||||
ISEL | X | X | X | X | |||||||
SCS | X | X | X | X | |||||||
Health Behaviors Survey | X | X | X | X | |||||||
Blood sample | X | X | X | ||||||||
Urine pregnancy test | X | X | X | ||||||||
Tablet counting | X | X | |||||||||
Study drug dispensation | X | ||||||||||
Review of side effects | X | X | X | ||||||||
PG-13 | X | X | X | X | X | X | X | X | X | X | |
Adverse event evaluation | X | X | X | X | X | X | X | X | X | X |